Abbott Laboratories
SGO:ABT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abbott Laboratories
SGO:ABT
|
US |
|
E
|
EDP Renovaveis SA
F:EDW
|
ES |
|
D
|
dynaCERT Inc
OTC:DYFSF
|
CA |
Wall St Price Targets
ABT Price Targets Summary
Abbott Laboratories
According to Wall Street analysts, the average 1-year price target for
ABT is 125.87 USD with a low forecast of 95.83 USD and a high forecast of 154.85 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABT's stock price target?
Price Target
125.87
USD
According to Wall Street analysts, the average 1-year price target for
ABT is 125.87 USD with a low forecast of 95.83 USD and a high forecast of 154.85 USD.
What is the Revenue forecast for Abbott Laboratories?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 7 years is 9%.
What is the Operating Income forecast for Abbott Laboratories?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 7 years is 14%.
What is the Net Income forecast for Abbott Laboratories?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 7 years is 15%.